Semaglutide for Metabolic Research
Appetite Regulation and Blood Sugar Control
$60.00
* This product is strictly for laboratory research use only and must not be used for human consumption, medical treatments, or any other non-research purposes.
What is Semaglutide?
Semaglutide is a GLP-1 receptor agonist that helps regulate blood sugar and reduce appetite. It is commonly researched for its effects in diabetes management and obesity due to its ability to improve satiety and reduce caloric intake.
Mechanism of Action:
Semaglutide mimics the action of GLP-1, a hormone that stimulates insulin secretion, reduces glucagon, and slows gastric emptying, resulting in reduced appetite and better glucose control.
Potential Benefits:
Weight Loss: Promotes satiety, leading to decreased caloric intake.
Blood Sugar Regulation: Useful in research focused on type 2 diabetes.
Appetite Control: Helps reduce cravings and portion sizes.
Metabolic Health: Potentially reduces risk factors associated with obesity.
Current Research Areas:
Diabetes and Blood Sugar Control: Extensively studied for glucose regulation.
Weight Management: Focus on obesity and calorie reduction.
Cardiovascular Health: Examined for reducing risks in diabetic patients.
Dosage and Administration:
Common Research Dosage: 0.25-1 mg weekly, administered subcutaneously.
Timing: Taken once weekly due to long half-life.
Additional Research References:
PubMed: Studies on Semaglutide in weight and diabetes research (PubMed).